Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro

1 Section on Oxidative Stress Tissue Injury, Laboratories of Physiological Studies and 2 Metabolic Control, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; 3 Department of Surgery, Medical School, University of Medicine and Dentistry of New Jers...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2009-05, Vol.296 (5), p.H1466-H1483
Hauptverfasser: Mukhopadhyay, Partha, Rajesh, Mohanraj, Batkai, Sandor, Kashiwaya, Yoshihiro, Hasko, Gyorgy, Liaudet, Lucas, Szabo, Csaba, Pacher, Pal
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page H1483
container_issue 5
container_start_page H1466
container_title American journal of physiology. Heart and circulatory physiology
container_volume 296
creator Mukhopadhyay, Partha
Rajesh, Mohanraj
Batkai, Sandor
Kashiwaya, Yoshihiro
Hasko, Gyorgy
Liaudet, Lucas
Szabo, Csaba
Pacher, Pal
description 1 Section on Oxidative Stress Tissue Injury, Laboratories of Physiological Studies and 2 Metabolic Control, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; 3 Department of Surgery, Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; 4 Department of Intensive Care Medicine, University Hospital, Lausanne, Switzerland; and 5 Department of Anesthesiology, The University of Texas Medical Branch, Galveston, Texas Submitted 30 July 2008 ; accepted in final form 9 March 2009 Doxorubicin (DOX) is a potent available antitumor agent; however, its clinical use is limited because of its cardiotoxicity. Cell death is a key component in DOX-induced cardiotoxicity, but its mechanisms are elusive. Here, we explore the role of superoxide, nitric oxide (NO), and peroxynitrite in DOX-induced cell death using both in vivo and in vitro models of cardiotoxicity. Western blot analysis, real-time PCR, immunohistochemistry, flow cytometry, fluorescent microscopy, and biochemical assays were used to determine the markers of apoptosis/necrosis and sources of NO and superoxide and their production. Left ventricular function was measured by a pressure-volume system. We demonstrated increases in myocardial apoptosis (caspase-3 cleavage/activity, cytochrome c release, and TUNEL), inducible NO synthase (iNOS) expression, mitochondrial superoxide generation, 3-nitrotyrosine (NT) formation, matrix metalloproteinase (MMP)-2/MMP-9 gene expression, poly(ADP-ribose) polymerase activation [without major changes in NAD(P)H oxidase isoform 1, NAD(P)H oxidase isoform 2, p22 phox , p40 phox , p47 phox , p67 phox , xanthine oxidase, endothelial NOS, and neuronal NOS expression] and decreases in myocardial contractility, catalase, and glutathione peroxidase activities 5 days after DOX treatment to mice. All these effects of DOX were markedly attenuated by peroxynitrite scavengers. Doxorubicin dose dependently increased mitochondrial superoxide and NT generation and apoptosis/necrosis in cardiac-derived H9c2 cells. DOX- or peroxynitrite-induced apoptosis/necrosis positively correlated with intracellular NT formation and could be abolished by peroxynitrite scavengers. DOX-induced cell death and NT formation were also attenuated by selective iNOS inhibitors or in iNOS knockout mice. Various NO donors when coadministered with DOX but not alone dramatically enhanced DOX-induced cell death with concomitant increased N
doi_str_mv 10.1152/ajpheart.00795.2008
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_19286953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1702224361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c536t-d0d36e601ac730f13bf6dafd02ac307a6cb4a067ed7c59b848e26b83bce08b133</originalsourceid><addsrcrecordid>eNpVUV1r2zAUFWNlSbP9gsEQe67TKymS7ZfBKOsHFAalfRaydB0rOJYn21nz7-s4Wds96UrnQ4d7CPnKYMmY5Jdm01ZoYr8ESHO55ADZBzIfEZ4wKfKPZA5CiUQxIWfkvOs2ACBTJT6RGct5pnIp5mTzEGqkoaTd0GIMz97hBW18H72lp5tpHJ2w_fTeI_UNdeE5xKHw1jeJb9xg0VGLdU0dmr46MHZ-FybtNPcxfCZnpak7_HI6F-Tp-tfj1W1y__vm7urnfWKlUH3iwAmFCpixqYCSiaJUzpQOuLECUqNssTKgUnSplXmRrTLkqshEYRGyggmxID-Ovu1QbNFZbPpoat1GvzVxr4Px-n-k8ZVeh53mKhsTwGjw_WQQw58Bu15vwhCbMbPmPJdZKsf9Log4kmwMXRexfP2AgT70o__1o6d-9KGfUfXtfbY3zamQkXB5JFR-Xf31EXVb7Tsf6rDevznyXGmpb9lKKfEC4Q2h5Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229587515</pqid></control><display><type>article</type><title>Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro</title><source>MEDLINE</source><source>American Physiological Society</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Mukhopadhyay, Partha ; Rajesh, Mohanraj ; Batkai, Sandor ; Kashiwaya, Yoshihiro ; Hasko, Gyorgy ; Liaudet, Lucas ; Szabo, Csaba ; Pacher, Pal</creator><creatorcontrib>Mukhopadhyay, Partha ; Rajesh, Mohanraj ; Batkai, Sandor ; Kashiwaya, Yoshihiro ; Hasko, Gyorgy ; Liaudet, Lucas ; Szabo, Csaba ; Pacher, Pal</creatorcontrib><description>1 Section on Oxidative Stress Tissue Injury, Laboratories of Physiological Studies and 2 Metabolic Control, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; 3 Department of Surgery, Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; 4 Department of Intensive Care Medicine, University Hospital, Lausanne, Switzerland; and 5 Department of Anesthesiology, The University of Texas Medical Branch, Galveston, Texas Submitted 30 July 2008 ; accepted in final form 9 March 2009 Doxorubicin (DOX) is a potent available antitumor agent; however, its clinical use is limited because of its cardiotoxicity. Cell death is a key component in DOX-induced cardiotoxicity, but its mechanisms are elusive. Here, we explore the role of superoxide, nitric oxide (NO), and peroxynitrite in DOX-induced cell death using both in vivo and in vitro models of cardiotoxicity. Western blot analysis, real-time PCR, immunohistochemistry, flow cytometry, fluorescent microscopy, and biochemical assays were used to determine the markers of apoptosis/necrosis and sources of NO and superoxide and their production. Left ventricular function was measured by a pressure-volume system. We demonstrated increases in myocardial apoptosis (caspase-3 cleavage/activity, cytochrome c release, and TUNEL), inducible NO synthase (iNOS) expression, mitochondrial superoxide generation, 3-nitrotyrosine (NT) formation, matrix metalloproteinase (MMP)-2/MMP-9 gene expression, poly(ADP-ribose) polymerase activation [without major changes in NAD(P)H oxidase isoform 1, NAD(P)H oxidase isoform 2, p22 phox , p40 phox , p47 phox , p67 phox , xanthine oxidase, endothelial NOS, and neuronal NOS expression] and decreases in myocardial contractility, catalase, and glutathione peroxidase activities 5 days after DOX treatment to mice. All these effects of DOX were markedly attenuated by peroxynitrite scavengers. Doxorubicin dose dependently increased mitochondrial superoxide and NT generation and apoptosis/necrosis in cardiac-derived H9c2 cells. DOX- or peroxynitrite-induced apoptosis/necrosis positively correlated with intracellular NT formation and could be abolished by peroxynitrite scavengers. DOX-induced cell death and NT formation were also attenuated by selective iNOS inhibitors or in iNOS knockout mice. Various NO donors when coadministered with DOX but not alone dramatically enhanced DOX-induced cell death with concomitant increased NT formation. DOX-induced cell death was also attenuated by cell-permeable SOD but not by cell-permeable catalase, the xanthine oxidase inhibitor allopurinol, or the NADPH oxidase inhibitors apocynine or diphenylene iodonium. Thus, peroxynitrite is a major trigger of DOX-induced cell death both in vivo and in vivo, and the modulation of the pathways leading to its generation or its effective neutralization can be of significant therapeutic benefit. heart failure; apoptosis; inducible nitric oxide synthase; hemodynamics Address for reprint requests and other correspondence: P. Pacher, Section on Oxidative Stress and Tissue Injury, Laboratory of Physiological Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, MSC-9413, Bethesda, MD 20892-9413 (e-mail: pacher{at}mail.nih.gov )</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>DOI: 10.1152/ajpheart.00795.2008</identifier><identifier>PMID: 19286953</identifier><identifier>CODEN: AJPPDI</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Animals ; Antibiotics, Antineoplastic - toxicity ; Antioxidants - metabolism ; Apoptosis ; Apoptosis - drug effects ; Cell Line ; Cells ; Dose-Response Relationship, Drug ; Doxorubicin - toxicity ; Enzyme Inhibitors - pharmacology ; Free Radical Scavengers - pharmacology ; Heart Diseases - chemically induced ; Heart Diseases - metabolism ; Heart Diseases - pathology ; Heart Diseases - physiopathology ; Heart Diseases - prevention &amp; control ; Male ; Matrix Metalloproteinase 2 - metabolism ; Matrix Metalloproteinase 9 - metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Mitochondria, Heart - drug effects ; Mitochondria, Heart - metabolism ; Mitochondria, Heart - pathology ; Myocardial Contraction - drug effects ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - metabolism ; Myocytes, Cardiac - pathology ; Necrosis ; Nitric oxide ; Nitric Oxide - metabolism ; Nitric Oxide Donors - pharmacology ; Nitric Oxide Synthase Type II - antagonists &amp; inhibitors ; Nitric Oxide Synthase Type II - deficiency ; Nitric Oxide Synthase Type II - genetics ; Permeability ; Peroxynitrous Acid - metabolism ; Poly(ADP-ribose) Polymerases - metabolism ; Rodents ; Superoxides - metabolism ; Toxicity ; Tumors ; Tyrosine - analogs &amp; derivatives ; Tyrosine - metabolism ; Ventricular Function, Left - drug effects ; Ventricular Pressure - drug effects</subject><ispartof>American journal of physiology. Heart and circulatory physiology, 2009-05, Vol.296 (5), p.H1466-H1483</ispartof><rights>Copyright American Physiological Society May 2009</rights><rights>Copyright © 2009, American Physiological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c536t-d0d36e601ac730f13bf6dafd02ac307a6cb4a067ed7c59b848e26b83bce08b133</citedby><cites>FETCH-LOGICAL-c536t-d0d36e601ac730f13bf6dafd02ac307a6cb4a067ed7c59b848e26b83bce08b133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3039,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19286953$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mukhopadhyay, Partha</creatorcontrib><creatorcontrib>Rajesh, Mohanraj</creatorcontrib><creatorcontrib>Batkai, Sandor</creatorcontrib><creatorcontrib>Kashiwaya, Yoshihiro</creatorcontrib><creatorcontrib>Hasko, Gyorgy</creatorcontrib><creatorcontrib>Liaudet, Lucas</creatorcontrib><creatorcontrib>Szabo, Csaba</creatorcontrib><creatorcontrib>Pacher, Pal</creatorcontrib><title>Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro</title><title>American journal of physiology. Heart and circulatory physiology</title><addtitle>Am J Physiol Heart Circ Physiol</addtitle><description>1 Section on Oxidative Stress Tissue Injury, Laboratories of Physiological Studies and 2 Metabolic Control, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; 3 Department of Surgery, Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; 4 Department of Intensive Care Medicine, University Hospital, Lausanne, Switzerland; and 5 Department of Anesthesiology, The University of Texas Medical Branch, Galveston, Texas Submitted 30 July 2008 ; accepted in final form 9 March 2009 Doxorubicin (DOX) is a potent available antitumor agent; however, its clinical use is limited because of its cardiotoxicity. Cell death is a key component in DOX-induced cardiotoxicity, but its mechanisms are elusive. Here, we explore the role of superoxide, nitric oxide (NO), and peroxynitrite in DOX-induced cell death using both in vivo and in vitro models of cardiotoxicity. Western blot analysis, real-time PCR, immunohistochemistry, flow cytometry, fluorescent microscopy, and biochemical assays were used to determine the markers of apoptosis/necrosis and sources of NO and superoxide and their production. Left ventricular function was measured by a pressure-volume system. We demonstrated increases in myocardial apoptosis (caspase-3 cleavage/activity, cytochrome c release, and TUNEL), inducible NO synthase (iNOS) expression, mitochondrial superoxide generation, 3-nitrotyrosine (NT) formation, matrix metalloproteinase (MMP)-2/MMP-9 gene expression, poly(ADP-ribose) polymerase activation [without major changes in NAD(P)H oxidase isoform 1, NAD(P)H oxidase isoform 2, p22 phox , p40 phox , p47 phox , p67 phox , xanthine oxidase, endothelial NOS, and neuronal NOS expression] and decreases in myocardial contractility, catalase, and glutathione peroxidase activities 5 days after DOX treatment to mice. All these effects of DOX were markedly attenuated by peroxynitrite scavengers. Doxorubicin dose dependently increased mitochondrial superoxide and NT generation and apoptosis/necrosis in cardiac-derived H9c2 cells. DOX- or peroxynitrite-induced apoptosis/necrosis positively correlated with intracellular NT formation and could be abolished by peroxynitrite scavengers. DOX-induced cell death and NT formation were also attenuated by selective iNOS inhibitors or in iNOS knockout mice. Various NO donors when coadministered with DOX but not alone dramatically enhanced DOX-induced cell death with concomitant increased NT formation. DOX-induced cell death was also attenuated by cell-permeable SOD but not by cell-permeable catalase, the xanthine oxidase inhibitor allopurinol, or the NADPH oxidase inhibitors apocynine or diphenylene iodonium. Thus, peroxynitrite is a major trigger of DOX-induced cell death both in vivo and in vivo, and the modulation of the pathways leading to its generation or its effective neutralization can be of significant therapeutic benefit. heart failure; apoptosis; inducible nitric oxide synthase; hemodynamics Address for reprint requests and other correspondence: P. Pacher, Section on Oxidative Stress and Tissue Injury, Laboratory of Physiological Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, MSC-9413, Bethesda, MD 20892-9413 (e-mail: pacher{at}mail.nih.gov )</description><subject>Animals</subject><subject>Antibiotics, Antineoplastic - toxicity</subject><subject>Antioxidants - metabolism</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Cell Line</subject><subject>Cells</subject><subject>Dose-Response Relationship, Drug</subject><subject>Doxorubicin - toxicity</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>Heart Diseases - chemically induced</subject><subject>Heart Diseases - metabolism</subject><subject>Heart Diseases - pathology</subject><subject>Heart Diseases - physiopathology</subject><subject>Heart Diseases - prevention &amp; control</subject><subject>Male</subject><subject>Matrix Metalloproteinase 2 - metabolism</subject><subject>Matrix Metalloproteinase 9 - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Mitochondria, Heart - drug effects</subject><subject>Mitochondria, Heart - metabolism</subject><subject>Mitochondria, Heart - pathology</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Myocytes, Cardiac - pathology</subject><subject>Necrosis</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Donors - pharmacology</subject><subject>Nitric Oxide Synthase Type II - antagonists &amp; inhibitors</subject><subject>Nitric Oxide Synthase Type II - deficiency</subject><subject>Nitric Oxide Synthase Type II - genetics</subject><subject>Permeability</subject><subject>Peroxynitrous Acid - metabolism</subject><subject>Poly(ADP-ribose) Polymerases - metabolism</subject><subject>Rodents</subject><subject>Superoxides - metabolism</subject><subject>Toxicity</subject><subject>Tumors</subject><subject>Tyrosine - analogs &amp; derivatives</subject><subject>Tyrosine - metabolism</subject><subject>Ventricular Function, Left - drug effects</subject><subject>Ventricular Pressure - drug effects</subject><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUV1r2zAUFWNlSbP9gsEQe67TKymS7ZfBKOsHFAalfRaydB0rOJYn21nz7-s4Wds96UrnQ4d7CPnKYMmY5Jdm01ZoYr8ESHO55ADZBzIfEZ4wKfKPZA5CiUQxIWfkvOs2ACBTJT6RGct5pnIp5mTzEGqkoaTd0GIMz97hBW18H72lp5tpHJ2w_fTeI_UNdeE5xKHw1jeJb9xg0VGLdU0dmr46MHZ-FybtNPcxfCZnpak7_HI6F-Tp-tfj1W1y__vm7urnfWKlUH3iwAmFCpixqYCSiaJUzpQOuLECUqNssTKgUnSplXmRrTLkqshEYRGyggmxID-Ovu1QbNFZbPpoat1GvzVxr4Px-n-k8ZVeh53mKhsTwGjw_WQQw58Bu15vwhCbMbPmPJdZKsf9Log4kmwMXRexfP2AgT70o__1o6d-9KGfUfXtfbY3zamQkXB5JFR-Xf31EXVb7Tsf6rDevznyXGmpb9lKKfEC4Q2h5Q</recordid><startdate>20090501</startdate><enddate>20090501</enddate><creator>Mukhopadhyay, Partha</creator><creator>Rajesh, Mohanraj</creator><creator>Batkai, Sandor</creator><creator>Kashiwaya, Yoshihiro</creator><creator>Hasko, Gyorgy</creator><creator>Liaudet, Lucas</creator><creator>Szabo, Csaba</creator><creator>Pacher, Pal</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TS</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20090501</creationdate><title>Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro</title><author>Mukhopadhyay, Partha ; Rajesh, Mohanraj ; Batkai, Sandor ; Kashiwaya, Yoshihiro ; Hasko, Gyorgy ; Liaudet, Lucas ; Szabo, Csaba ; Pacher, Pal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c536t-d0d36e601ac730f13bf6dafd02ac307a6cb4a067ed7c59b848e26b83bce08b133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Antibiotics, Antineoplastic - toxicity</topic><topic>Antioxidants - metabolism</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Cell Line</topic><topic>Cells</topic><topic>Dose-Response Relationship, Drug</topic><topic>Doxorubicin - toxicity</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>Heart Diseases - chemically induced</topic><topic>Heart Diseases - metabolism</topic><topic>Heart Diseases - pathology</topic><topic>Heart Diseases - physiopathology</topic><topic>Heart Diseases - prevention &amp; control</topic><topic>Male</topic><topic>Matrix Metalloproteinase 2 - metabolism</topic><topic>Matrix Metalloproteinase 9 - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Mitochondria, Heart - drug effects</topic><topic>Mitochondria, Heart - metabolism</topic><topic>Mitochondria, Heart - pathology</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Myocytes, Cardiac - pathology</topic><topic>Necrosis</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Donors - pharmacology</topic><topic>Nitric Oxide Synthase Type II - antagonists &amp; inhibitors</topic><topic>Nitric Oxide Synthase Type II - deficiency</topic><topic>Nitric Oxide Synthase Type II - genetics</topic><topic>Permeability</topic><topic>Peroxynitrous Acid - metabolism</topic><topic>Poly(ADP-ribose) Polymerases - metabolism</topic><topic>Rodents</topic><topic>Superoxides - metabolism</topic><topic>Toxicity</topic><topic>Tumors</topic><topic>Tyrosine - analogs &amp; derivatives</topic><topic>Tyrosine - metabolism</topic><topic>Ventricular Function, Left - drug effects</topic><topic>Ventricular Pressure - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mukhopadhyay, Partha</creatorcontrib><creatorcontrib>Rajesh, Mohanraj</creatorcontrib><creatorcontrib>Batkai, Sandor</creatorcontrib><creatorcontrib>Kashiwaya, Yoshihiro</creatorcontrib><creatorcontrib>Hasko, Gyorgy</creatorcontrib><creatorcontrib>Liaudet, Lucas</creatorcontrib><creatorcontrib>Szabo, Csaba</creatorcontrib><creatorcontrib>Pacher, Pal</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mukhopadhyay, Partha</au><au>Rajesh, Mohanraj</au><au>Batkai, Sandor</au><au>Kashiwaya, Yoshihiro</au><au>Hasko, Gyorgy</au><au>Liaudet, Lucas</au><au>Szabo, Csaba</au><au>Pacher, Pal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><addtitle>Am J Physiol Heart Circ Physiol</addtitle><date>2009-05-01</date><risdate>2009</risdate><volume>296</volume><issue>5</issue><spage>H1466</spage><epage>H1483</epage><pages>H1466-H1483</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><coden>AJPPDI</coden><abstract>1 Section on Oxidative Stress Tissue Injury, Laboratories of Physiological Studies and 2 Metabolic Control, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; 3 Department of Surgery, Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; 4 Department of Intensive Care Medicine, University Hospital, Lausanne, Switzerland; and 5 Department of Anesthesiology, The University of Texas Medical Branch, Galveston, Texas Submitted 30 July 2008 ; accepted in final form 9 March 2009 Doxorubicin (DOX) is a potent available antitumor agent; however, its clinical use is limited because of its cardiotoxicity. Cell death is a key component in DOX-induced cardiotoxicity, but its mechanisms are elusive. Here, we explore the role of superoxide, nitric oxide (NO), and peroxynitrite in DOX-induced cell death using both in vivo and in vitro models of cardiotoxicity. Western blot analysis, real-time PCR, immunohistochemistry, flow cytometry, fluorescent microscopy, and biochemical assays were used to determine the markers of apoptosis/necrosis and sources of NO and superoxide and their production. Left ventricular function was measured by a pressure-volume system. We demonstrated increases in myocardial apoptosis (caspase-3 cleavage/activity, cytochrome c release, and TUNEL), inducible NO synthase (iNOS) expression, mitochondrial superoxide generation, 3-nitrotyrosine (NT) formation, matrix metalloproteinase (MMP)-2/MMP-9 gene expression, poly(ADP-ribose) polymerase activation [without major changes in NAD(P)H oxidase isoform 1, NAD(P)H oxidase isoform 2, p22 phox , p40 phox , p47 phox , p67 phox , xanthine oxidase, endothelial NOS, and neuronal NOS expression] and decreases in myocardial contractility, catalase, and glutathione peroxidase activities 5 days after DOX treatment to mice. All these effects of DOX were markedly attenuated by peroxynitrite scavengers. Doxorubicin dose dependently increased mitochondrial superoxide and NT generation and apoptosis/necrosis in cardiac-derived H9c2 cells. DOX- or peroxynitrite-induced apoptosis/necrosis positively correlated with intracellular NT formation and could be abolished by peroxynitrite scavengers. DOX-induced cell death and NT formation were also attenuated by selective iNOS inhibitors or in iNOS knockout mice. Various NO donors when coadministered with DOX but not alone dramatically enhanced DOX-induced cell death with concomitant increased NT formation. DOX-induced cell death was also attenuated by cell-permeable SOD but not by cell-permeable catalase, the xanthine oxidase inhibitor allopurinol, or the NADPH oxidase inhibitors apocynine or diphenylene iodonium. Thus, peroxynitrite is a major trigger of DOX-induced cell death both in vivo and in vivo, and the modulation of the pathways leading to its generation or its effective neutralization can be of significant therapeutic benefit. heart failure; apoptosis; inducible nitric oxide synthase; hemodynamics Address for reprint requests and other correspondence: P. Pacher, Section on Oxidative Stress and Tissue Injury, Laboratory of Physiological Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, MSC-9413, Bethesda, MD 20892-9413 (e-mail: pacher{at}mail.nih.gov )</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>19286953</pmid><doi>10.1152/ajpheart.00795.2008</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0363-6135
ispartof American journal of physiology. Heart and circulatory physiology, 2009-05, Vol.296 (5), p.H1466-H1483
issn 0363-6135
1522-1539
language eng
recordid cdi_pubmed_primary_19286953
source MEDLINE; American Physiological Society; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Animals
Antibiotics, Antineoplastic - toxicity
Antioxidants - metabolism
Apoptosis
Apoptosis - drug effects
Cell Line
Cells
Dose-Response Relationship, Drug
Doxorubicin - toxicity
Enzyme Inhibitors - pharmacology
Free Radical Scavengers - pharmacology
Heart Diseases - chemically induced
Heart Diseases - metabolism
Heart Diseases - pathology
Heart Diseases - physiopathology
Heart Diseases - prevention & control
Male
Matrix Metalloproteinase 2 - metabolism
Matrix Metalloproteinase 9 - metabolism
Mice
Mice, Inbred C57BL
Mice, Knockout
Mitochondria, Heart - drug effects
Mitochondria, Heart - metabolism
Mitochondria, Heart - pathology
Myocardial Contraction - drug effects
Myocytes, Cardiac - drug effects
Myocytes, Cardiac - metabolism
Myocytes, Cardiac - pathology
Necrosis
Nitric oxide
Nitric Oxide - metabolism
Nitric Oxide Donors - pharmacology
Nitric Oxide Synthase Type II - antagonists & inhibitors
Nitric Oxide Synthase Type II - deficiency
Nitric Oxide Synthase Type II - genetics
Permeability
Peroxynitrous Acid - metabolism
Poly(ADP-ribose) Polymerases - metabolism
Rodents
Superoxides - metabolism
Toxicity
Tumors
Tyrosine - analogs & derivatives
Tyrosine - metabolism
Ventricular Function, Left - drug effects
Ventricular Pressure - drug effects
title Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T02%3A37%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20superoxide,%20nitric%20oxide,%20and%20peroxynitrite%20in%20doxorubicin-induced%20cell%20death%20in%20vivo%20and%20in%20vitro&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Mukhopadhyay,%20Partha&rft.date=2009-05-01&rft.volume=296&rft.issue=5&rft.spage=H1466&rft.epage=H1483&rft.pages=H1466-H1483&rft.issn=0363-6135&rft.eissn=1522-1539&rft.coden=AJPPDI&rft_id=info:doi/10.1152/ajpheart.00795.2008&rft_dat=%3Cproquest_pubme%3E1702224361%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229587515&rft_id=info:pmid/19286953&rfr_iscdi=true